David M. Knott’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

David M. Knott’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.09M	Buy	10,416 +864	+9%	+$205K	0.76%	35
2021 Q2	$2.44M	Buy	9,552 +334	+4%	+$83.4K	0.87%	33
2021 Q1	$2.45M	Sell	9,218 -617	-6%	-$194K	1.05%	28
2020 Q4	$3.63M	Buy	9,835 +657	+7%	+$188K	1.64%	15
2020 Q3	$2.24M	Buy	9,178 +386	+4%	+$120K	1.31%	18
2020 Q2	$2.53M	Hold	8,792	–	–	1.38%	17
2020 Q1	$1.79M	Buy	8,792 +977	+13%	+$311K	1.13%	21
2019 Q4	$3.49M	Hold	7,815	–	–	1.42%	17
2019 Q3	$2.4M	Buy	7,815 +583	+8%	+$189K	1.01%	20
2019 Q2	$2.3M	Buy	7,232 +2,854	+65%	+$988K	0.97%	21
2019 Q1	$1.84M	Hold	4,378	–	–	0.73%	30
2018 Q4	$1.33M	Buy	4,378 +1,022	+30%	+$330K	0.63%	32
2018 Q3	$1.21M	Buy	3,356 +297	+10%	+$102K	0.39%	38
2018 Q2	$1.12M	Buy	3,059 +997	+48%	+$355K	0.42%	38
2018 Q1	$609K	Buy	2,062 +1,329	+181%	+$393K	0.25%	55
2017 Q4	$307K	Buy	733 +373	+104%	+$133K	0.12%	72
2017 Q3	$119K	Buy	+360	New	+$98.1K	0.05%	85

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $131M AUM 46.14% 1-Year Est. Return

David M. Knott's EIGR Position: Q3 2021 in Review

David M. Knott increased its Eiger BioPharmaceuticals, Inc. (EIGR) stake by 9% in Q3 2021, buying an estimated $205K and bringing the position to 10,416 shares worth $2.09M. The position accounts for 0.76% of the portfolio, ranked #35.

David M. Knott first reported a position in EIGR in Q3 2017 and has held it in 17 quarters since. The position peaked at $3.63M in Q4 2020. 92 funds tracked by Wall St. Rank hold EIGR as of Q3 2021.

David M. Knott held 10,416 shares of Eiger BioPharmaceuticals, Inc. worth $2.09M as of Q3 2021.
David M. Knott bought 864 Eiger BioPharmaceuticals, Inc. shares in Q3 2021, an estimated $205K.
Eiger BioPharmaceuticals, Inc. made up 0.76% of David M. Knott's portfolio in Q3 2021, its #35 holding.
David M. Knott first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2017 and has held it in 17 quarters since.
David M. Knott's Eiger BioPharmaceuticals, Inc. position peaked at $3.63M in Q4 2020.
92 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.